Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Cellective Therapeutics
company
About
Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases.
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $27.50M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2003
- Operating Status
- Active
Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases. Cellective focuses on monoclonal antibodies, which, with the company's technology, can be developed so specifically that they block the root causes of autoimmunity without interfering with the body's normal response to infections.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$27.50M
Cellective Therapeutics has raised a total of
$27.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 29, 2004 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 29, 2004 | Series A | $27.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Cellective Therapeutics is funded by 1 investors.
BA Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
